News | September 11, 2007

FlowCardia Finalizes Enrollment in Catheter Study in CTOs

September 12, 2007 - FlowCardia Inc., a medical device company developing a portfolio of endovascular devices for the treatment of coronary and peripheral chronic total occlusions (CTOs), announced the completion of enrollment into the PATRIOT study (Peripheral Approach To Recanalization In Occluded Totals), which is designed to assess the safety and efficacy of the peripheral line of CROSSER Catheters in lower limb CTOs.

FlowCardia’s study includes eight hospitals and 85 patients. The CROSSER is a rapid exchange catheter delivered over standard .014-in and .018-in guidewires to the site of a CTO. Utilizing high frequency vibration, the CROSSER Catheter is designed to cross CTOs allowing for subsequent debulking, balloon angioplasty and stent placement. The CROSSER 14P, CROSSER 14S and CROSSER 18 Catheters were studied in the PATRIOT Trial.

"The device worked well in the upper leg and also proved safe and effective crossing the more difficult, below the knee occlusions. This new endovascular line of catheters will help us cross lesions that previously could only be treated with a more invasive open surgery," said Dr. Jim Joye, M.D., the PATRIOT Study principle investigator.

For more information: www.flowcardia.com

Related Content

Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Teleflex, FDA 510k clearance, TrapLiner Catheter, U.S. launch
Technology | Catheters| March 02, 2017
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
Merit Medical Systems, SwiftNINJA Steerable Microcatheter, FDA 510(k) clearance
Technology | Catheters| November 09, 2016
November 9, 2016 — Merit Medical Systems Inc.
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters| July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
Roxwood Medical, MicroCross Catheter, full U.S. launch

Image courtesy of Roxwood Medical

Technology | Catheters| January 07, 2016
Roxwood Medical Inc. reported that more than 500 patients have been successfully treated as part of the initial limited...
Overlay Init